4.3 Article

Synergistic Anticancer Effect of Gemcitabine Combined With Impressic Acid or Acankoreanogein in Panc-1 Cells by Inhibiting NF-κB and Stat 3 Activation

Journal

NATURAL PRODUCT COMMUNICATIONS
Volume 15, Issue 12, Pages -

Publisher

SAGE PUBLICATIONS INC
DOI: 10.1177/1934578X20974239

Keywords

pancreatic cancer; impressic acid; acankoreanogein; gemcitabine

Funding

  1. Youth Foundation of Wuyi University [2017td01]
  2. Department of Education of Guangdong Province [2017KSYS010, 2016KCXTD005, 2017KZDXM084, 2019KZDZX2003, 2019KZDXM035]

Ask authors/readers for more resources

Natural products have presented potentiality to improve the outcomes of cancer therapies. Impressic acid (E12-1) and acankoreanogein (E13-1), important activity compounds in Acanthopanax trifoliatus (L) Merr., show widely biological activities. In this study, we isolated E12-1 and E13-1 from Acanthopanax tnfoliatus (L.) Merr., and investigated their improvement effect in gemcitabine (GEM) treatment in Panc-1 cells. The results showed that GEM in combination with E12-1 or E13-1 showed stronger inhibition on the growth and induction of apoptosis in Panc-1 cells compared to GEM, E12-1, or E13-1 alone. GEM in combination with E12-1 or E13-1 also strongly inhibited cell migration. Mechanistic investigation showed that GEM in combination with E12-tor E13-1 effectively inhibited the activition of nuclear factor kappa-light-chain-enhancer of activated B cells and Stat 3. Overall, GEM in combination with E12-1 or E13-1 might be an effective strategy for the prevention of prostate cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available